|UNC named 12th U.S. HHT Center of Excellence by HHT Foundation|
|Monday, March 14, 2011|
Today HHT Foundation International announced that the University of North Carolina at Chapel Hill has been selected as the 12th HHT Center of Excellence in the United States.
Raj Kasthuri, MD, assistant professor of hematology and oncology in the UNC School of Medicine, is director of the new center for the treatment of hereditary hemorrhagic telangiectasia (HHT). HHT, also known as Osler-Weber-Rendu syndrome, is an inherited disorder of the blood vessels that can cause excessive bleeding. The most common symptom of HHT is bleeding from the nose, but HHT can also cause bleeding from the mouth, tongue, gastrointestinal tract, lungs, skin or other organs.
For full release